Constraint Induced or Multi-Modal aphasia rehabilitation: A Randomised Controlled Trial (RCT) for stroke related chronic aphasia

Lead PI: A/Prof Miranda Rose

Status: Completed

No. of Patients Currently Recruited: 216                          No. of Patients Required:  216

COMPARE is a randomized controlled trial of 216 participants comparing Constraint Induced Aphasia Therapy and Multi-modality Aphasia Therapy to usual care for people with aphasia 6 months to 15 years following stroke. Primary outcome is aphasia severity immediately following treatment plus secondary outcomes at 3 months post treatment. An economic analysis will occur. COMPARE is now running 10 locations around Australia and New Zealand.  

Trial URL:

ANZCTR No: ACTRN126125000618550

23 June 2021

Related Posts